Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Metabolism, Inborn Errors D008661 46 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Peritonitis D010538 38 associated lipids
Hemorrhage D006470 15 associated lipids
Proteinuria D011507 30 associated lipids
Spasm D013035 5 associated lipids
Lymphoma D008223 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Thalassemia D013789 8 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Archer SL and Roudebush WE Enhancement of sperm motility using pentoxifylline and platelet-activating factor. 2013 Methods Mol. Biol. pmid:22992918
Flasiński M et al. Interactions between single-chained ether phospholipids and sphingomyelin in mixed monolayers at the air/water interface-Grazing incidence X-ray diffraction and Brewster angle microscopy studies. 2013 Colloids Surf B Biointerfaces pmid:23777791
Grotta MB et al. Obesity increases eosinophil activity in asthmatic children and adolescents. 2013 BMC Pulm Med pmid:23773659
Eriksson AC and Whiss PA Nanomolar concentrations of adrenaline induce platelet adhesion in vitro. 2013 Platelets pmid:22471400
Zhou Z et al. Chemical constituents of Callicarpa nudiflora and their anti-platelet aggregation activity. 2013 Fitoterapia pmid:23669034
Wang TM et al. Alkyl and phenolic glycosides from Saussurea stella. 2013 Fitoterapia pmid:23567860
Schäfer-Somi S et al. Vascular endothelial (VEGF) and epithelial growth factor (EGF) as well as platelet-activating factor (PAF) and receptors are expressed in the early pregnant canine uterus. 2013 Reprod. Domest. Anim. pmid:22458960
Stanca E et al. Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: potential antiinflammatory effect of silybin. 2013 Biochim. Biophys. Acta pmid:23851051
Nagase T [Respiratory failure]. 2013 Nippon Rinsho pmid:23855209
Tao YK et al. Elevated platelet activating factor level in ischemia-related arrhythmia and its electrophysiological effect on myocardium. 2013 Biomed. Environ. Sci. pmid:23611129
Vitte J and Bongrand P Serum tryptase determination in patients with acute allergic reactions. 2013 J. Allergy Clin. Immunol. pmid:23643096
Vadas P Reply: To PMID 23040367. 2013 J. Allergy Clin. Immunol. pmid:23643097
Vlachogianni IC et al. Interleukin-1beta stimulates platelet-activating factor production in U-937 cells modulating both its biosynthetic and catabolic enzymes. 2013 Cytokine pmid:23673285
Hirayama F Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. 2013 Br. J. Haematol. pmid:23215650
Harleton E et al. Ability to induce atrial fibrillation in the peri-operative period is associated with phosphorylation-dependent inhibition of TWIK protein-related acid-sensitive potassium channel 1 (TASK-1). 2013 J. Biol. Chem. pmid:23229553
Detopoulou P et al. Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy. 2013 Curr Heart Fail Rep pmid:23389700
Wang HL et al. Differential inhibitory effects of 2-azafluorenones on PI-PLC activation but not on PC-PLC- or PC-PLD-activation induced by histamine, PAF, PMA or A23187 in C6 glioma cells. 2013 Chin J Physiol pmid:23347011
Wei JF et al. Induction of mast-cell accumulation by promutoxin, an Arg-49 phospholipase A2. 2013 Biomed Res Int pmid:23509689
Forsman H et al. Reactivation of desensitized formyl peptide receptors by platelet activating factor: a novel receptor cross talk mechanism regulating neutrophil superoxide anion production. 2013 PLoS ONE pmid:23555913
Ruchaud-Sparagano MH et al. Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis. 2013 Respirology pmid:23730995
Miyamoto-Sasaki M et al. Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients. 2013 J. Atheroscler. Thromb. pmid:23739642
Nankar SA et al. Differential interaction of peptides derived from C-terminal domain of human apolipoprotein E with platelet activating factor analogs. 2013 Biochimie pmid:23376877
Detopoulou P et al. Baseline and 6-Week follow-up levels of PAF and activity of its metabolic enzymes in patients with heart failure and healthy volunteers--a pilot study. 2013 Angiology pmid:23000600
Xu B et al. Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers. 2013 Br. J. Cancer pmid:23949154
Alevizos M et al. Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor. 2013 Ann. Allergy Asthma Immunol. pmid:24267366
Cui H et al. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice. 2013 J. Allergy Clin. Immunol. pmid:24021572
Flasiński M et al. Cholesterol as a factor regulating the influence of natural (PAF and lysoPAF) vs synthetic (ED) ether lipids on model lipid membranes. 2013 Biochim. Biophys. Acta pmid:23906729
Kim YH et al. PAF enhances MMP-2 production in rat aortic VSMCs via a β-arrestin2-dependent ERK signaling pathway. 2013 J. Lipid Res. pmid:23911909
Fodran P and Minnaard AJ Catalytic synthesis of enantiopure mixed diacylglycerols – synthesis of a major M. tuberculosis phospholipid and platelet activating factor. 2013 Org. Biomol. Chem. pmid:24191360
Fontbonne H et al. Activation of bile salt dependent lipase by (lyso)phosphatidic acid and platelet activating factor. 2013 FEBS Lett. pmid:23891620
Feuerherm AJ et al. Platelet-activating factor induces proliferation in differentiated keratinocytes. 2013 Mol. Cell. Biochem. pmid:23975504
Guerrero AT et al. The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. 2013 Naunyn Schmiedebergs Arch. Pharmacol. pmid:23187752
Shi YM et al. Lancolides, antiplatelet aggregation nortriterpenoids with tricyclo[6.3.0.0(2,11)]undecane-bridged system from Schisandra lancifolia. 2013 Org. Lett. pmid:24059675
Kang JW et al. Anti-platelet activity of erythro-(7S,8R)-7-acetoxy-3,4,3',5'-tetramethoxy-8-O-4'-neolignan from Myristica fragrans. 2013 Phytother Res pmid:23296979
Bitencourt CS et al. Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury. 2013 J. Cell. Mol. Med. pmid:24373549
Sahu RP et al. Platelet-activating factor does not mediate UVB-induced local immune suppression. 2012 Mar-Apr Photochem. Photobiol. pmid:22211638
Zia-ul-Haq M et al. Platelet aggregation and anti-inflammatory effects of garden pea, Desi chickpea and Kabuli chickpea. 2012 Jul-Aug Acta Pol Pharm pmid:22876614
Chini M et al. Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: ii) study of the abacavir/lamivudine/efavirenz HAART regimen. 2012 Jan-Mar Int J Immunopathol Pharmacol pmid:22507337
Chini M et al. Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen. 2012 AIDS Res. Hum. Retroviruses pmid:22050695
Nordin N et al. Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum. 2012 Pharm Biol pmid:22103812
Huang LG et al. [Effects of glycomacropeptide on damage to intestinal tissue and apoptosis of intestinal epithelial cells in neonatal rats with necrotizing enterocolitis]. 2012 Zhonghua Er Ke Za Zhi pmid:22932017
Pawlowic MC and Zhang K Leishmania parasites possess a platelet-activating factor acetylhydrolase important for virulence. 2012 Mol. Biochem. Parasitol. pmid:22954769
Nitoda E et al. Ocular actions of platelet-activating factor: clinical implications. 2012 Expert Opin. Ther. Targets pmid:22924390
Sahu RP et al. Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis. 2012 Carcinogenesis pmid:22223848
Iyú D et al. The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. 2012 Thromb. Haemost. pmid:22318645
Xu LF et al. Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. 2012 Inflammation pmid:21452036
Gorman S and Hart PH The current state of play of rodent models to study the role of vitamin D in UV-induced immunomodulation. 2012 Photochem. Photobiol. Sci. pmid:22898802
Zhang XT et al. [Study on the pharmacokinetics of ginkgolide B for injection in rats]. 2012 Zhong Yao Cai pmid:22876684
Saadawi S et al. Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin Eâ‚‚ and Thromboxane Bâ‚‚ production and platelet activating factor receptor binding. 2012 Molecules pmid:22538486
Oh SF et al. Resolvin E2 formation and impact in inflammation resolution. 2012 J. Immunol. pmid:22450811